| 0.4 |
1.2 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.2 |
0.5 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 0.1 |
0.4 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.1 |
0.3 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.1 |
1.1 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.3 |
GO:1903660 |
negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.1 |
0.1 |
GO:0071393 |
cellular response to progesterone stimulus(GO:0071393) |
| 0.1 |
0.4 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
0.3 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.3 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.1 |
0.3 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
0.1 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.0 |
0.2 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.0 |
0.2 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.0 |
0.6 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.2 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.0 |
0.3 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.1 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.0 |
0.9 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.3 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.1 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
0.6 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.2 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.0 |
0.2 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 |
0.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.0 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.0 |
GO:0060560 |
developmental growth involved in morphogenesis(GO:0060560) |
| 0.0 |
0.3 |
GO:0003056 |
regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.0 |
0.1 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.0 |
0.1 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.0 |
0.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.1 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.0 |
0.1 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) |
| 0.0 |
0.1 |
GO:1904924 |
negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.0 |
0.2 |
GO:0032621 |
interleukin-18 production(GO:0032621) |
| 0.0 |
0.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.1 |
GO:1904588 |
cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 |
0.4 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.0 |
0.1 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
0.3 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 |
0.6 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.0 |
0.1 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 |
0.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.1 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.0 |
0.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.1 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.1 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.1 |
GO:0060298 |
positive regulation of sarcomere organization(GO:0060298) |
| 0.0 |
0.1 |
GO:1990051 |
activation of protein kinase C activity(GO:1990051) |
| 0.0 |
0.1 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.0 |
0.8 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0019082 |
viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.0 |
0.1 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.0 |
0.1 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.1 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.1 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.0 |
0.1 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.2 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.0 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.0 |
0.1 |
GO:1903826 |
arginine transmembrane transport(GO:1903826) |
| 0.0 |
0.0 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.0 |
0.3 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.0 |
0.1 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.0 |
0.1 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.1 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.0 |
0.1 |
GO:0070295 |
transformation of host cell by virus(GO:0019087) renal water absorption(GO:0070295) |
| 0.0 |
0.0 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.1 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.1 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 |
0.1 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.1 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
0.0 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 |
0.1 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.0 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.0 |
0.0 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.0 |
GO:0038129 |
ERBB3 signaling pathway(GO:0038129) |
| 0.0 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |